Abstract
The extracellular matrix protein tenascin (TN) is overexpressed in a number of solid tumours. Thi however, is the first study to examine TN expression in ovarian tumours. TN protein was examined in froze sections of 50 human ovarian tumours by immunohistochemistry. Malignant and borderline tumours showed significantly greater incidence and intensity of stromal staining than benign tumours (P < 0.0001 and P = 0.038 respectively). Seven omental metastases were also examined and showed a strikingly similar protein distribution to their primary tumour counterparts. The expression pattern of different RNA isoforms, created by alternative splicing of the primary transcript, was identified using reverse transcription-polymerase chain reactions (RT-PCR). The smallest TN RNA splice variant (284 bp) was found in all tumours examined, while the appearance of larger molecular weight transcripts (approximately 490 and 556 bp), as major forms, was predominantly limited to malignant tumours, with 9/12 malignant tumours showing this pattern compared with 1/6 benign tumours. These data suggest that malignant ovarian tumours have increased expression of TN compared with benign tumours and this may be associated with induction of specific isoforms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, K., Langdon, S., Lessells, A. et al. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br J Cancer 74, 999–1004 (1996). https://doi.org/10.1038/bjc.1996.480
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.480
This article is cited by
-
Current progress in the inflammatory background of angiogenesis in gynecological cancers
Inflammation Research (2019)
-
Clinical significance of serum tenascin-c levels in epithelial ovarian cancer
Tumor Biology (2014)
-
Association of invasion-promoting tenascin-C additional domains with breast cancers in young women
Breast Cancer Research (2010)
-
Expression of tenascin-C and its isoforms in the breast
Cancer and Metastasis Reviews (2010)
-
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
Breast Cancer Research (2009)